≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Family history of certain disabilities and chronic diseases leading to disablement

MESH Endpoint Browser

Z21_FAMILY_HISTORY_CERTA_DISABILITI_CHRONIC_DISEA_LEADI_DISABL

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — Z82
  • Cause of death: ICD-10 — Z82

2 out of 7 registries used, show all original rules.

1897

4. Check minimum number of events

None

1897

5. Include endpoints

None

1897

6. Filter based on genotype QC (FinnGen only)

1897

Control definitions (FinnGen only)

Control exclude
Z21_PERSONS_W_POTEN_HEALTH_HAZARDS_RELATED_FAMILY_PERSONAL_HISTORY_CERTA_CONDI_INFLUENCI_HEALTH_STATUS

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Z[8-9]

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1897 1408 489
Unadjusted period prevalence (%) 0.41 0.48 0.22
Median age at first event (years) 38.61 36.59 44.45

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1630
Matched controls
16299
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z31.5
ICD-10 Finland
Genetic counselling
33.2
323.0
703
364
Z82.7
ICD-10 Finland
Family history of congenital malformations, deformations and chromosomal abnormalities
+∞
323.0
553
*
Z82.4
ICD-10 Finland
Family history of ischaemic heart disease and other diseases of the circulatory system
1009.8
323.0
387
5
Z82.3
ICD-10 Finland
Family history of stroke
3165.4
295.9
277
*
Z82.0
ICD-10 Finland
Family history of epilepsy and other diseases of the nervous system
+∞
245.1
229
*
Z82.6
ICD-10 Finland
Family history of arthritis and other diseases of the musculoskeletal system and connective tissue
+∞
102.2
97
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
4.4
94.6
395
1101
Z82.8
ICD-10 Finland
Family history of other disabilities and chronic diseases leading to disablement, not elsewhere classified
+∞
85.1
81
*
Z87.5
ICD-10 Finland
Personal history of complications of pregnancy, childbirth and the puerperium
142.2
52.1
55
*
O35.8
ICD-10 Finland
Maternal care for other (suspected) fetal abnormality and damage
7.1
49.3
126
191
MAA10
NOMESCO Finland
Biopsy of chorionic villus
39.5
48.5
61
16
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
10.9
44.0
86
83
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
3.6
43.4
211
640
WX610
NOMESCO Finland
Patient controlled analgesia
19.1
38.5
59
32
Z82.1
ICD-10 Finland
Family history of blindness and visual loss
+∞
35.5
34
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.9
33.9
148
407
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
2.5
29.7
264
1178
XF404
NOMESCO Finland
Ambulatory ECG
3.4
28.4
147
464
O35.2
ICD-10 Finland
Maternal care for (suspected) hereditary disease in fetus
31.5
28.2
37
12
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.6
27.3
213
880
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
+∞
26.1
25
*
O35.1
ICD-10 Finland
Maternal care for (suspected) chromosomal abnormality in fetus
5.1
25.8
84
173
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
4.0
25.3
105
276
Z82.5
ICD-10 Finland
Family history of asthma and other chronic lower respiratory diseases
+∞
24.0
23
*
Z84.8
ICD-10 Finland
Family history of other specified conditions
65.9
22.9
26
*
MAA00
NOMESCO Finland
Amniocentesis
4.2
22.4
87
215
SPAT1263
SPAT
Sampling
1.7
21.9
701
5029
Z96.1
ICD-10 Finland
Presence of intraocular lens
9.0
21.4
45
51
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
7.5
19.5
46
63
Z35.2
ICD-10 Finland
Supervision of pregnancy with other poor reproductive or obstetric history
4.0
18.8
77
201
I42.2
ICD-10 Finland
Other hypertrophic cardiomyopathy
14.7
17.6
29
20
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
85.9
15.6
17
*
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
161.4
15.5
16
*
O35.9
ICD-10 Finland
Maternal care for (suspected) fetal abnormality and damage, unspecified
5.9
15.5
43
75
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
2.0
15.3
218
1184
AA9CW
NOMESCO Finland
NA
32.0
14.8
19
6
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
14.7
558
4065
O35.0
ICD-10 Finland
Maternal care for (suspected) central nervous system malformation in fetus
19.3
14.2
21
11
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
14.2
362
2375
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
7.9
13.9
31
40
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.6
13.8
100
395
O80.8
ICD-10 Finland
Other single spontaneous delivery
2.3
13.6
124
556
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
5.8
13.3
37
65
FM1NE
NOMESCO Finland
Ultrasound examination of fetal heart
8.3
12.5
27
33
XF402
NOMESCO Finland
ECG with work load test
2.4
12.5
111
489
Z83.4
ICD-10 Finland
Family history of other endocrine, nutritional and metabolic diseases
+∞
12.5
12
*
Q87.4
ICD-10 Finland
Marfan syndrome
24.5
12.5
17
7
FP4B5
NOMESCO Finland
ECG, prolonged recording (24 h)
8.5
12.3
26
31
SPAT1379
SPAT
Health check-up of pregnant person
1.7
12.0
297
1919
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
9.7
11.7
23
24
SPAT1301
SPAT
No procedures
1.5
11.6
437
3143
I71.9
ICD-10 Finland
Aortic aneurysm of unspecified site, without mention of rupture
8.7
11.5
24
28
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
4.6
11.2
38
85
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
1.8
11.1
202
1192
FM1QE
NOMESCO Finland
Extensive ultrasound of fetal heart
5.7
10.9
30
53
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.1
10.9
118
574
AA1AD
NOMESCO Finland
CT of head and brain
1.7
10.6
229
1424
O02.1
ICD-10 Finland
Missed abortion
2.1
10.5
126
636
O04.6
ICD-10 Finland
Medical abortion, complete or unspecified, complicated by delayed or excessive haemorrhage
4.4
10.5
37
86
I42.1
ICD-10 Finland
Obstructive hypertrophic cardiomyopathy
14.3
10.5
17
12
Z97.4
ICD-10 Finland
Presence of external hearing-aid
+∞
10.4
10
*
Z82.2
ICD-10 Finland
Family history of deafness and hearing loss
+∞
10.4
10
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
10.3
281
1862
W78
ICPC
Pregnancy
1.5
10.2
364
2571
Z35.9
ICD-10 Finland
Supervision of high-risk pregnancy, unspecified
2.4
9.9
80
338
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.1
9.6
111
556
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.3
9.6
86
382
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.4
9.5
498
3813
XF640
NOMESCO Finland
NA
5.0
9.4
29
59
I42.0
ICD-10 Finland
Dilated cardiomyopathy
5.6
9.4
26
47
I71.00
ICD-10 Finland
Dissecting aneurysm of aorta (ruptured) [any part]
21.8
9.3
13
6
O28.3
ICD-10 Finland
Abnormal ultrasonic finding on antenatal screening of mother
4.6
9.3
31
69
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
9.3
604
4810
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
3.5
9.2
41
119
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.7
9.1
213
1351
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
9.1
446
3362
Z39.2
ICD-10 Finland
Routine postpartum follow-up
1.5
8.9
306
2139
SPAT1260
SPAT
Consultation of another employee
1.6
8.9
245
1624
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
16.4
8.6
13
8
C07AB07
ATC
bisoprolol; oral
1.4
8.5
403
3012
SPAT1197
SPAT
Extensive health check-up of expecting family
1.5
8.4
320
2290
SPAT1097
SPAT
Recording of ECG
1.8
8.2
146
853
I45.8
ICD-10 Finland
Other specified conduction disorders
14.5
8.2
13
9
SPAT1196
SPAT
Monitoring of normal pregnancy
1.7
8.1
174
1078
O04.1
ICD-10 Finland
Medical abortion, incomplete, complicated by delayed or excessive haemorrhage
4.2
8.1
29
70
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
8.1
86
416
LCH11
NOMESCO Finland
Pharmacologic abortion
2.0
8.0
103
536
TFP00
NOMESCO Finland
Temporary use of transvenous or epicardial pacemaker
22.1
8.0
11
5
W90
ICPC
Uncompl labour/delivery livebirth
1.9
8.0
121
673
SPAT1189
SPAT
Other ultrasound examination during pregnancy
2.1
8.0
92
459
SPAT1375
SPAT
Structural ultrasound screening, weeks 18+0-21+6
3.1
7.9
41
135
W84
ICPC
Pregnancy high risk
2.1
7.8
84
409
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
1.5
7.8
246
1683
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
1.6
7.7
190
1221
R06AE07
ATC
cetirizine; oral
1.3
7.6
666
5522
R06.0
ICD-10 Finland
Dyspnoea
1.5
7.6
264
1847
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
25.1
7.6
10
*
D82
ICPC
Teeth/gum disease
1.4
7.5
559
4514
SPAT1312
SPAT
General health counselling
1.4
7.5
483
3808
G60.0
ICD-10 Finland
Hereditary motor and sensory neuropathy
10.9
7.3
13
12
PD5AD
NOMESCO Finland
CT of aorta
6.9
7.3
17
25
XFE00
NOMESCO Finland
Epicardial ultrasonography
3.7
7.2
29
79
R51.80
ICD-10 Finland
Headache
1.5
7.2
242
1679
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
7.0
323
2390
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.8
7.0
121
702
WX872
NOMESCO Finland
Intensive care
2.7
6.9
45
172
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
6.9
160
1017
R03AC02
ATC
salbutamol; inhalant
1.3
6.8
757
6467
SPAT1373
SPAT
Combined screening in early pregnancy
2.5
6.8
51
209
AJ1
HP
Reconstruction of the aortic base, eg composite graft, incl. valve saving operation
40.2
6.8
8
*
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
40.2
6.8
8
*
R89.8
ICD-10 Finland
Abnormal findings in specimens from other organs, systems and tissues, other abnormal findings
40.2
6.8
8
*
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.5
6.7
49
200
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.8
6.7
120
705
O04.4
ICD-10 Finland
Medical abortion, incomplete, without complication
5.0
6.5
19
38
H02AB06
ATC
prednisolone; systemic
1.3
6.4
570
4705
C09CA06
ATC
candesartan; oral
1.5
6.4
229
1608
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
3.2
6.3
31
99
-31
ICPC
Medical examin/health eval partial
1.9
6.3
92
506
G47.3
ICD-10 Finland
Sleep apnoea
1.5
6.3
224
1574
G71.11
ICD-10 Finland
Dystrophia myotonica [Steinert]
18.1
6.3
9
5
MB2AA
NOMESCO Finland
Total body X-ray examination of fetus mortus
+∞
6.3
6
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.8
6.2
106
613
FCA75
NOMESCO Finland
Valve-sparing repair of aortic root (David, Yacoub)
26.8
6.2
8
*
I49.5
ICD-10 Finland
Sick sinus syndrome
5.4
6.2
17
32
SPAT1380
SPAT
Postpartum check-up
1.5
6.1
228
1620
C08CA01
ATC
amlodipine; oral
1.4
6.1
256
1862
SPAT1281
SPAT
Other administrative function
1.7
6.1
113
673
O36.4
ICD-10 Finland
Maternal care for intrauterine death
6.7
6.0
14
21

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
486
2148
2.70
70.46
2.7
2.3
ng/l
692.5
669.6
0.07
373
1717
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
31
14
22.49
42.05
1.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
209
816
2.75
37.06
1.8
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
658
4152
1.90
35.63
7.1
5.0
inr
1.2
1.1
1.24
216
1341
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
165
610
2.87
32.32
2.6
2.1
ng/l
98.4
95.2
0.05
147
540
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
212
952
2.38
27.85
1.9
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
228
1060
2.31
27.65
1.8
1.5
—
—
—
0
0
(3013512) EKG study
486
3046
1.80
25.33
3.6
2.7
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
51
105
4.96
23.49
1.0
1.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
603
4157
1.66
21.70
3.1
2.5
ng/l
39.2
45.1
0.15
299
2012
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
277
1531
1.95
21.09
2.5
2.2
u/l
4178.9
6103.2
0.71
127
622
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
256
1454
1.88
17.80
3.9
3.4
%
31.6
31.8
0.15
203
1063
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
484
3352
1.60
16.27
1.9
2.0
u/l
147.8
208.4
1.16
457
3191
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
579
4288
1.50
14.03
2.1
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
615
4630
1.49
13.67
5.2
5.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1655
15177
1.71
13.46
11.4
9.4
mmol/l
3.9
3.9
0.30
1617
14721
(3044889) 12 lead EKG panel
1101
9277
1.45
13.41
3.2
2.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1650
15134
1.69
13.22
11.3
9.4
mmol/l
139.6
139.6
0.51
1611
14709
(3037467) Urinalysis macro (dipstick) panel - Urine
1224
10538
1.46
13.16
4.2
3.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
314
2054
1.63
13.05
3.3
2.7
ng/l
156.7
412.5
1.78
185
1179
(3013826) Glucose [Moles/volume] in Serum or Plasma
932
7688
1.42
12.32
3.9
3.7
mmol/l
6.2
6.4
2.18
811
6938
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
546
4095
1.47
12.08
2.2
2.3
u/l
54.9
55.6
0.17
498
3810
(40761536) Microorganisms panel - Urine sediment
218
1328
1.72
11.83
3.2
3.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1410
12576
1.47
11.81
4.4
4.0
pmol/l
14.5
14.4
1.15
1295
11721
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
860
7042
1.40
11.61
4.2
3.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1155
9964
1.41
11.39
4.1
3.6
e6/l
3720.4
895.5
—
8
105
(3019309) Folate [Moles/volume] in Red Blood Cells
274
1795
1.62
11.23
1.7
1.6
nmol/l
1113.6
1165.1
0.49
226
1398
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
57
211
2.75
11.20
3.2
2.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
52
185
2.86
11.00
1.6
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
944
7904
1.39
10.92
3.3
2.7
ug/l
71.7
78.8
1.02
886
7457
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1582
14536
1.53
10.61
5.1
4.6
mu/l
1.7
1.9
1.32
1491
13716
(3019832) Treponema pallidum Ab [Presence] in Serum
479
3581
1.45
10.55
2.1
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
322
2230
1.53
10.32
1.9
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
21
45
4.71
9.30
1.5
1.2
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
69
311
2.26
9.01
4.9
5.4
mmol/l
1.1
1.2
0.60
63
266
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
67
301
2.27
8.83
1.5
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
174
1083
1.67
8.69
2.6
2.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
314
2248
1.48
8.47
1.4
1.4
titre
719.1
545.0
0.42
45
439
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
15
26
5.81
8.33
1.1
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
791
6635
1.33
8.19
4.4
4.9
umol/l
9.8
10.6
2.25
740
6259
(3024561) Albumin [Mass/volume] in Serum or Plasma
625
5075
1.35
8.04
4.6
3.8
g/l
36.5
36.8
0.79
574
4723
(3019225) pH of Specimen
171
1083
1.64
7.98
3.6
2.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
220
1482
1.55
7.92
1.8
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1759
16770
1.67
7.80
12.0
8.9
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
62
286
2.21
7.71
1.5
1.2
u/ml
102.3
112.5
0.27
25
57
(46235355) HIV 1 and 2 tests - Meaningful Use set
644
5279
1.33
7.70
2.3
2.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
332
2461
1.42
7.39
1.6
1.5
pmol/l
414.4
34746579.7
2.94
282
2147
(3013707) Erythrocyte sedimentation rate by Westergren method
1215
10911
1.32
7.35
3.8
3.5
mm/h
9.0
9.5
0.89
1132
10223
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
435
3391
1.37
7.16
1.9
1.7
mg/l
0.7
1.0
2.27
313
2490
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
35
128
2.77
7.14
1.4
1.3
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
10
5
20.09
7.13
1.1
1.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1667
15752
1.48
7.12
10.9
9.5
mg/l
19.1
20.4
0.90
1306
11971
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
18
43
4.22
7.01
1.5
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
45
980
0.45
6.97
1.4
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
12
20
6.03
6.90
1.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
45
976
0.45
6.89
1.3
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
209
1438
1.51
6.82
2.8
1.9
%
24.6
24.7
0.04
171
1242
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
426
3335
1.36
6.79
2.5
2.0
mg/l
2.7
2.7
0.22
369
2863
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1173
10540
1.30
6.76
6.3
6.0
u/l
71.3
74.0
2.23
1120
9934
(3043238) Trisomy 21 risk [Likelihood] in Fetus
48
1000
0.47
6.60
1.3
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1442
13345
1.34
6.59
3.8
3.7
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1718
16385
1.51
6.47
11.9
10.1
umol/l
70.7
69.5
1.28
1718
16377
(3042733) HLA Ab [Presence] in Serum
10
7
14.35
6.39
7.2
2.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
538
4393
1.31
6.37
2.8
2.6
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
31
114
2.75
6.29
2.0
2.0
mg/l
10.3
18.4
—
9
41
(3023368) Bacteria identified in Blood by Culture
356
2742
1.37
6.25
3.4
3.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
638
5342
1.29
6.24
2.0
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1222
11101
1.28
6.15
3.0
2.7
u/l
36.8
37.0
0.04
1154
10613
(3004789) Transferrin [Mass/volume] in Serum or Plasma
224
1596
1.46
6.14
2.8
1.9
g/l
2.5
2.5
1.06
210
1474
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
235
1695
1.44
6.04
1.8
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
696
5918
1.28
5.97
3.3
3.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
198
1390
1.47
5.86
1.9
2.0
nmol/l
362.0
381.1
0.71
180
1278
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
46
212
2.20
5.81
1.4
1.3
—
73.3
—
0
6
(3003338) MCHC [Mass/volume]
1360
14539
0.77
5.80
13.7
12.1
g/l
333.7
333.1
1.51
1349
14433
(3004616) Nuclear Ab [Presence] in Serum
40
176
2.30
5.64
1.5
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
11
21
5.26
5.52
1.0
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
160
1092
1.51
5.44
2.0
2.3
e9/l
3.9
4.1
0.85
137
934
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
136
899
1.55
5.36
2.4
3.0
mmol/l
1.2
1.2
0.25
116
765
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
29
113
2.59
5.30
1.4
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
79
456
1.76
5.27
3.3
2.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
480
3945
1.29
5.27
3.4
3.3
estimate
0.0
0.0
1.34
194
1411
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
612
5196
1.26
5.14
5.0
4.4
mmol/l
1.2
1.2
0.30
544
4722
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
364
2892
1.32
5.13
1.3
1.3
iu/ml
26.5
25.1
0.07
119
887
(3023520) Reticulocytes [#/volume] in Blood
111
708
1.60
5.11
2.7
2.8
e9/l
69.1
71.9
0.37
83
518
(3022948) Iron [Moles/volume] in Serum or Plasma
239
1781
1.39
5.10
2.8
1.9
umol/l
15.0
14.7
0.27
221
1643
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
156
1075
1.49
5.08
3.1
3.8
u/l
247.9
241.1
0.16
146
1015
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1517
14293
1.31
5.07
3.8
3.5
mmol/l
5.6
5.7
1.39
1420
13356
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
12
27
4.47
5.04
1.0
1.2
mg/l
0.5
167.2
—
6
21
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
79
464
1.73
4.98
7.9
8.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
19
61
3.14
4.92
1.1
2.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
792
6951
1.24
4.90
5.2
5.5
%
2.8
2.8
0.25
746
6508
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
64
355
1.83
4.89
2.0
2.1
g/l
1.2
1.4
1.05
51
313
(3009343) pH of Capillary blood
98
614
1.63
4.86
3.3
2.8
ph
7.4
7.4
—
8
65
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
72
415
1.76
4.85
3.6
2.9
mmol/l
24.6
24.7
0.13
66
391
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
60
327
1.86
4.85
1.5
1.6
mmol/l
8.1
7.5
1.25
36
200
(3035350) Ketones [Presence] in Urine by Test strip
849
7522
1.23
4.77
3.2
3.0
estimate
0.0
0.0
0.80
190
1400
(3024731) MCV [Entitic volume]
1844
18015
1.84
4.73
16.9
14.2
fl
89.9
90.0
0.23
1832
17835
(3035941) MCH [Entitic mass]
1844
18015
1.84
4.73
16.9
14.2
pg
30.1
30.0
0.16
1832
17833
(3026361) Erythrocytes [#/volume] in Blood
1844
18017
1.84
4.70
17.0
14.3
e12/l
4.5
4.5
0.51
1820
17615
(3019069) Monocytes/100 leukocytes in Blood
794
6997
1.23
4.66
5.5
5.7
%
7.9
8.1
1.25
754
6605
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
95
598
1.62
4.64
3.3
2.8
mmol/l
1.2
1.4
0.20
69
428
(3010813) Leukocytes [#/volume] in Blood
1844
18022
1.83
4.62
17.0
14.3
e9/l
6.8
6.7
0.36
1821
17613
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
98
623
1.60
4.60
3.3
2.8
kpa
5.0
5.1
0.85
92
586
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
29
122
2.40
4.57
1.2
1.8
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
88
546
1.64
4.55
5.8
7.1
mmol/l
24.3
24.4
0.04
81
499
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
86
531
1.65
4.54
1.5
1.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1844
18028
1.82
4.53
17.0
14.4
g/l
135.9
136.1
0.26
1831
17841
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
69
403
1.74
4.47
2.0
2.4
g/l
3.6
3.6
0.05
59
380
(3007461) Platelets [#/volume] in Blood
1841
17995
1.78
4.45
17.0
14.3
e9/l
258.0
262.1
2.35
1823
17615
(3018677) aPTT in Platelet poor plasma by Coagulation assay
218
1639
1.37
4.42
1.8
1.9
s
28.4
29.2
1.26
205
1578
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
77
466
1.68
4.39
1.2
1.2
u/ml
68.9
29.3
—
7
31
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
69
407
1.72
4.33
1.8
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
291
2295
1.32
4.29
1.8
2.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
823
7329
1.22
4.23
5.2
5.5
%
30.2
29.7
0.71
786
6904
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
66
389
1.72
4.16
1.4
1.4
u/l
12.1
19.8
3.02
56
336
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
71
428
1.68
4.13
1.2
1.3
u/ml
15.0
8.7
—
7
75
(3022096) Basophils/100 leukocytes in Blood
756
6693
1.22
4.08
5.3
5.6
%
0.7
0.7
0.28
716
6281
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
7
10.03
4.01
1.0
1.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
146
1043
1.43
3.99
2.6
2.8
%
1.6
1.7
0.30
123
932
(3018010) Neutrophils/100 leukocytes in Blood
810
7237
1.21
3.94
5.0
5.3
%
55.8
56.3
0.61
773
6826
(3011412) CD3 cells [#/volume] in Blood
28
125
2.26
3.90
2.8
2.6
e9/l
1.1
1.2
0.50
18
74
(3021601) Nitrite [Presence] in Urine by Test strip
841
7548
1.21
3.88
4.4
4.2
estimate
0.0
0.0
0.50
200
1437
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
80
506
1.61
3.88
1.2
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
846
7605
1.20
3.82
3.3
3.1
estimate
0.0
0.0
0.27
191
1393
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
553
4774
1.22
3.78
1.8
1.7
pmol/l
99.5
97.3
0.47
303
2621
(3013115) Eosinophils [#/volume] in Blood
856
7715
1.20
3.73
5.2
5.8
e9/l
0.2
0.2
0.40
788
6893
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1369
12894
1.22
3.70
4.4
4.2
mmol/mol
37.7
37.8
0.16
1281
12200
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1714
16583
1.35
3.62
8.7
7.9
u/l
26.4
25.8
0.64
1667
16110
(3037121) Protein [Mass/volume] in Urine
67
413
1.65
3.62
2.6
3.3
g/l
0.2
0.3
0.34
23
174
(3026493) Urate [Moles/volume] in Serum or Plasma
386
3221
1.25
3.61
2.2
2.1
umol/l
2451.5
4454.9
0.78
345
2863
(3022145) Colonoscopy Study observation
191
1454
1.35
3.60
1.3
1.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
827
7451
1.19
3.56
5.0
5.6
e9/l
0.0
0.0
0.08
760
6523
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
659
5817
1.20
3.55
5.8
4.9
mmol/l
1.2
1.2
0.12
515
4920
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
39
206
1.91
3.54
1.3
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
825
7435
1.19
3.54
5.0
5.6
e9/l
0.5
0.5
0.21
758
6512
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
335
2757
1.26
3.53
1.3
1.3
u/ml
7.4
9.7
0.36
134
1145
(3048689) Calprotectin [Mass/mass] in Stool
290
2347
1.28
3.51
2.8
2.5
ug/g
96.0
102.6
0.12
224
1856
(3044009) aPTT.lupus sensitive (LA screen)
9
17
5.31
3.51
1.0
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
25
112
2.25
3.48
1.2
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
572
4990
1.21
3.48
2.8
2.9
u/l
27.2
29.6
2.08
541
4765
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
69
2.62
3.47
1.1
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
12
333
0.36
3.43
1.3
1.8
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
16
58
2.77
3.42
1.1
1.1
%
105.8
96.9
—
8
27
(3019198) Lymphocytes [#/volume] in Blood
855
7751
1.19
3.38
4.9
5.5
e9/l
2.0
2.0
0.52
795
6951
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
39
212
1.86
3.27
1.2
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
6
7
8.59
3.26
1.0
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
70
452
1.57
3.17
1.9
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
37
200
1.87
3.17
2.4
2.7
u/ml
0.4
0.4
0.18
23
97
(40758558) Short blood count panel - Blood
299
3590
0.80
3.08
5.3
5.9
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
6
8
7.52
3.05
1.2
1.0
ng/l
110.0
69.1
—
6
8
(4034850)
23
465
0.49
3.05
7.9
8.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
10
29
3.46
3.05
1.1
8.4
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
16
62
2.59
3.04
1.1
1.1
%
98.9
94.3
—
8
29
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
21
93
2.27
3.03
3.1
2.6
e9/l
0.2
0.2
0.29
21
80
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1492
14268
1.21
3.00
3.3
3.1
mmol/l
1.2
1.2
0.03
1386
13491
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
148
1118
1.35
2.97
2.7
3.3
pmol/l
4.5
4.6
0.78
135
996
(4010399)
121
886
1.39
2.94
1.4
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
46
273
1.70
2.92
1.0
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
482
4198
1.20
2.92
1.3
1.3
u/ml
1.2
1.4
0.34
113
1155
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
92
1293
0.70
2.91
1.6
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
60
382
1.59
2.91
1.2
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
100
710
1.43
2.90
1.3
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
7
13
5.40
2.87
1.0
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
26
129
2.03
2.86
1.2
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
38
215
1.78
2.85
2.9
3.1
mmol/l
2.5
2.3
0.17
23
126
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
136
1021
1.36
2.85
2.2
2.2
g/l
0.2
0.2
0.01
129
959
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
19
83
2.30
2.84
1.2
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1607
15506
1.24
2.84
11.7
10.3
%
40.6
40.3
0.94
1178
12701
(3019060) Gas panel - Arterial blood
81
555
1.48
2.83
4.7
4.9
—
—
—
0
0
(3019174) dRVVT (LA screen)
8
18
4.46
2.79
1.0
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
14
5.01
2.73
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
185
1462
1.29
2.72
1.2
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1566
15087
1.22
2.71
4.0
3.7
mmol/l
2.8
2.9
0.91
1459
14242
(3027974) Hepatitis B virus e Ag [Presence] in Serum
6
10
6.02
2.70
2.7
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
18
79
2.29
2.67
1.2
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
22
106
2.09
2.63
3.6
3.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
225
1832
1.26
2.61
1.2
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
15
4.68
2.59
1.0
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
439
3829
1.19
2.59
2.4
2.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
63
418
1.52
2.59
2.1
2.4
%
160.5
161.7
0.04
58
402
(3021960) Folate [Moles/volume] in Serum or Plasma
302
2548
1.22
2.53
1.5
1.4
nmol/l
21.4
20.6
0.45
266
2252
(3018095) Leukocytes [#/volume] in Urine
426
4852
0.84
2.50
3.2
3.0
e6/l
46.0
72.9
0.62
285
3144
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
26
3.47
2.48
1.0
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
11
39
2.83
2.47
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1544
14887
1.20
2.47
3.7
3.4
mmol/l
1.5
1.5
0.40
1439
14101
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1548
14936
1.20
2.42
3.7
3.5
mmol/l
4.7
4.8
1.04
1448
14201
(4038314)
6
12
5.01
2.40
1.8
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
139
1077
1.31
2.39
1.9
2.4
g/l
10.0
10.5
1.23
122
994
(3020682) Albumin/Creatinine [Ratio] in Urine
350
3012
1.20
2.39
4.2
3.9
mg/mmol
10.7
9.4
0.16
214
1921
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
99
729
1.38
2.38
4.4
2.7
ng/l
86.7
64.9
1.85
91
654
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
30
514
0.58
2.38
1.8
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
46
290
1.60
2.37
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
21
104
2.03
2.36
5.6
2.6
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
68
469
1.47
2.35
2.4
2.2
umol/l
6.3
4.9
0.44
48
343
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
47
299
1.59
2.34
1.9
1.8
ug/l
113.8
414.4
1.24
41
273
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
77
546
1.43
2.31
1.4
1.3
ug/l
3.1
3.6
0.64
70
515
(3044640) Blood type and Crossmatch panel - Blood
500
4450
1.17
2.29
2.0
1.9
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
14
59
2.38
2.29
1.1
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
145
1138
1.30
2.28
1.7
1.6
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
13
53
2.46
2.27
1.3
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
13
4.63
2.27
1.0
1.2
—
—
—
0
0
(4306422)
44
279
1.59
2.23
1.1
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
31
179
1.74
2.23
1.6
1.3
nmol/l
—
0.4
—
0
9
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
29
3.11
2.22
9.4
4.7
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
20
100
2.01
2.21
2.4
2.3
%
12.0
13.1
0.25
11
54
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
46
296
1.57
2.20
1.4
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
149
1180
1.29
2.20
1.3
1.3
u/ml
134.2
236.8
2.12
135
1102
(3000330) Specific gravity of Urine by Test strip
37
588
0.62
2.20
3.1
2.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
141
1109
1.29
2.19
1.6
1.6
mu/l
324.2
297.5
0.23
121
991
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
80
2.14
2.18
1.1
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
25
136
1.85
2.18
1.0
1.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
155
1926
0.79
2.17
2.7
2.4
e6/l
3.7
3.4
0.11
71
970
(3009214) Lutropin [Units/volume] in Serum or Plasma
95
707
1.36
2.16
1.5
1.4
u/l
9.2
9.1
0.03
86
574
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
6
14
4.30
2.15
7.0
4.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
7
19
3.69
2.15
1.0
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
9
30
3.01
2.14
1.9
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
293
2509
1.20
2.12
1.8
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
375
3282
1.18
2.11
3.5
3.3
kg/l
1.0
1.0
0.24
77
490
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
10
37
2.71
2.10
1.1
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
10
37
2.71
2.10
1.1
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
292
3385
0.84
2.08
3.6
3.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
31
2.91
2.07
1.1
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
31
2.91
2.07
1.1
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
7
20
3.51
2.05
1.0
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
404
3567
1.17
2.04
1.7
1.6
mmol/l
1.3
1.4
0.21
344
3120
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
6
15
4.01
2.04
1.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
53
359
1.49
2.04
1.4
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
8
26
3.09
2.01
2.0
1.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
411
3641
1.16
1.99
3.3
3.1
mmol/l
8.0
8.2
0.38
346
3140
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
41
264
1.57
1.98
2.6
3.8
%
55.4
56.3
0.19
41
264
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
16
3.76
1.93
1.0
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
40
258
1.56
1.93
2.6
3.6
e9/l
3.5
4.1
1.35
40
258
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
41
266
1.55
1.93
1.1
1.3
u/ml
6.7
5.4
0.10
20
114
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
27
157
1.73
1.93
1.2
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
50
339
1.49
1.93
1.4
1.1
u/ml
259.9
237.5
0.24
34
205
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
92
1201
0.75
1.91
1.5
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
80
1065
0.74
1.90
1.8
1.8
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
92
1200
0.75
1.90
1.5
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
27
158
1.72
1.89
1.2
1.3
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
5
139
0.36
1.88
4.8
14.5
nmol/l
342.6
834.8
—
5
133
(3028026) IgM [Mass/volume] in Serum or Plasma
107
830
1.31
1.88
1.4
1.8
g/l
1.2
1.4
0.98
94
774
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
92
1198
0.76
1.88
1.5
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
43
284
1.53
1.88
1.1
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
339
3848
0.86
1.87
2.9
2.6
e6/l
58.1
69.1
0.15
259
2860
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
66
475
1.40
1.87
1.8
1.9
g/l
0.2
0.2
0.17
61
443
(4094501)
47
317
1.49
1.86
1.1
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
92
1196
0.76
1.86
1.5
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
70
510
1.39
1.85
2.1
2.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
127
1010
1.28
1.85
6.6
7.0
mmol/l
1.1
1.0
0.20
91
770
(3020491) Glucose [Moles/volume] in Blood
22
122
1.81
1.84
1.4
1.5
mmol/l
6.0
6.2
0.11
17
95
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
137
1101
1.26
1.84
2.4
2.3
au/ml
12.3
21.0
—
8
94
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
12
4.17
1.82
1.0
1.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
144
1166
1.25
1.81
1.8
1.6
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
46
311
1.49
1.81
3.0
3.4
mg/l
1.1
1.2
0.64
40
287
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
31
191
1.63
1.81
1.0
1.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
328
2877
1.17
1.80
3.4
3.2
mg/l
506.9
291.2
0.29
199
1842
(3001186) Copper [Moles/volume] in Serum or Plasma
9
35
2.58
1.80
1.0
1.5
umol/l
18.8
17.5
—
9
30
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
27
161
1.69
1.78
1.5
1.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
127
1017
1.27
1.76
6.7
7.0
kpa
12.8
13.2
0.39
118
969
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
127
1017
1.27
1.76
6.7
7.0
kpa
5.1
5.1
0.27
119
969
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
19
102
1.87
1.76
1.2
1.1
u/l
96.3
66.2
—
7
69
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
10
41
2.45
1.75
3.1
2.8
—
—
—
0
0
(3000492) Spirometry study
191
1602
1.21
1.74
1.4
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
36
2.51
1.74
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
29
178
1.64
1.73
1.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
24
2.92
1.72
2.0
1.4
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
7
24
2.92
1.72
6.1
3.1
mmol/l
26.0
25.2
—
7
24
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
13
3.85
1.71
1.8
1.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
18
96
1.88
1.70
2.6
2.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
14
68
2.07
1.70
1.0
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
26
156
1.68
1.69
1.2
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
26
156
1.68
1.69
1.2
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
26
156
1.68
1.69
1.2
1.3
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
11
49
2.25
1.63
4.9
5.3
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
11
49
2.25
1.63
2.5
2.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
37
245
1.52
1.63
1.3
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
168
2001
0.82
1.63
2.2
2.5
mmol/l
2.4
2.4
0.22
144
1733
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
26
158
1.65
1.62
1.2
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
26
158
1.65
1.62
1.2
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
27
166
1.64
1.61
1.3
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
903
8517
1.11
1.59
6.5
8.1
e9/l
4.0
4.0
0.08
830
7469
(3002256) Pathology report gross observation
206
1757
1.19
1.59
1.2
1.2
—
—
—
0
0
(44806118)
23
136
1.70
1.59
1.3
1.4
—
—
—
0
0
(44790047)
23
136
1.70
1.59
1.3
1.4
—
—
—
0
0
(44790048)
23
136
1.70
1.59
1.3
1.4
—
—
—
0
0
(44790049)
23
136
1.70
1.59
1.3
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
37
247
1.51
1.58
1.3
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
186
1573
1.20
1.58
1.6
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
35
231
1.52
1.57
1.3
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
312
3514
0.87
1.55
3.0
2.5
e6/l
0.3
0.3
0.06
232
2561
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
639
5920
1.12
1.55
2.4
2.2
nmol/l
76.7
73.5
2.03
591
5511
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
21
122
1.73
1.54
1.4
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
34
225
1.52
1.52
2.7
2.2
g/l
136.6
132.5
0.43
26
166
(40768443) Skin Pathology biopsy report
69
521
1.34
1.51
1.2
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
21
2.86
1.50
7.0
4.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
21
2.86
1.50
7.0
4.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
175
2059
0.83
1.50
2.6
2.3
e6/l
0.7
1.3
1.44
90
1099
(3035637) Corticotropin [Mass/volume] in Plasma
25
154
1.63
1.50
1.9
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
250
2180
1.17
1.50
4.2
3.9
ug/l
1.9
2.0
0.21
226
1985
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
40
275
1.46
1.50
1.1
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
17
94
1.82
1.47
4.4
2.4
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
19
109
1.75
1.46
1.2
1.4
mmol/l
2.1
1.8
0.42
19
100
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
19
109
1.75
1.46
2.2
2.5
e6/l
705.2
783.9
—
10
38
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
10
45
2.23
1.46
1.0
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
31
203
1.54
1.46
1.2
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
38
2.37
1.45
1.1
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
38
2.37
1.45
1.1
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
38
2.37
1.45
1.0
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
24
148
1.63
1.44
2.8
1.7
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
14
73
1.92
1.44
1.4
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
31
204
1.53
1.43
3.1
2.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
28
180
1.56
1.43
2.4
2.1
%
19.0
16.9
—
10
84
(3025130) Human papilloma virus identified in Specimen
24
375
0.64
1.42
1.4
1.7
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
76
589
1.30
1.41
2.1
2.0
u/l
45.8
40.4
1.26
66
549
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
51
372
1.38
1.40
1.1
1.2
u/ml
21.1
40.9
—
7
39
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
73
563
1.31
1.40
2.4
2.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
189
1.54
1.40
1.3
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
416
3779
1.13
1.40
3.3
4.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
25
158
1.59
1.37
1.1
1.5
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
6
23
2.61
1.36
1.2
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
21
127
1.66
1.36
1.7
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
45
323
1.40
1.36
1.3
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
49
357
1.38
1.36
2.2
2.0
mg/l
11.2
10.2
0.34
44
335
(4015189)
5
17
2.95
1.36
3.4
1.9
—
—
—
0
0
(4268621)
28
183
1.54
1.34
1.8
2.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
81
638
1.28
1.34
1.7
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
40
282
1.43
1.34
1.2
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
199
1721
1.17
1.34
2.8
2.7
mmol/l
0.8
0.8
0.71
183
1615
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
43
308
1.41
1.32
1.6
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
40
0.00
1.32
0.0
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
40
283
1.42
1.32
1.2
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
186
1602
1.18
1.32
1.2
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
15
83
1.81
1.31
3.3
2.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
173
1482
1.18
1.31
1.3
1.2
iu/ml
147.8
164.7
0.20
66
572
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
37
259
1.44
1.29
3.2
2.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
319
3540
0.88
1.28
2.9
2.4
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
12
62
1.94
1.27
1.2
2.2
u/l
181.9
191.4
0.35
12
62
(3051651) Icteric interference index of Serum or Plasma
12
62
1.94
1.27
3.7
2.5
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
35
2.29
1.27
1.0
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
9
44
2.05
1.27
1.0
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
125
1043
1.21
1.26
1.2
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
115
952
1.22
1.25
2.2
2.1
nmol/l
10.9
11.8
0.50
103
852
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
14
77
1.82
1.25
1.1
1.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
6
25
2.40
1.24
1.3
1.4
mu/l
34.4
77.9
—
6
20
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
25
2.40
1.24
1.0
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
639
5982
1.10
1.23
1.9
1.9
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
24
155
1.56
1.23
1.2
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
175
1511
1.17
1.22
2.0
2.1
umol/l
6.5
7.3
0.27
136
1276
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
364
3310
1.12
1.21
2.1
1.9
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
26
2.31
1.18
5.0
6.3
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
6
26
2.31
1.18
1.0
1.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
60
463
1.31
1.18
1.9
2.1
%
96.8
94.4
0.43
54
423
(3001556) Androgen free Index in Serum or Plasma
8
38
2.11
1.18
2.0
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
19
117
1.63
1.18
2.4
2.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
38
273
1.40
1.18
2.2
2.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
114
1360
0.83
1.17
1.5
1.6
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
42
566
0.74
1.17
10.5
8.5
%
1.0
1.4
2.79
42
561
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
22
141
1.57
1.17
1.1
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
96
787
1.23
1.16
1.6
1.5
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
42
565
0.74
1.16
10.5
8.6
%
0.6
0.7
0.47
42
560
(3036489) Thrombin time
68
536
1.28
1.15
1.8
2.0
s
21.8
20.7
0.47
53
453
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
20
2.50
1.15
1.8
3.0
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
12
65
1.85
1.13
1.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
5
112
0.44
1.13
1.0
1.3
—
1.5
—
0
6
(3044290) Cell count panel - Cerebral spinal fluid
43
319
1.36
1.11
1.2
1.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
109
1298
0.83
1.11
2.9
2.0
u/l
31.6
71.7
0.55
89
1092
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21
135
1.56
1.11
1.3
1.5
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
31
2.26
1.10
2.6
2.5
ug/l
84.3
74.9
—
7
31
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
31
2.26
1.10
1.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
99
821
1.22
1.09
1.4
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
227
2018
1.14
1.09
1.9
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
504
4691
1.10
1.09
1.8
1.7
—
—
—
0
0
(3020891) Body temperature
26
374
0.69
1.08
3.5
4.5
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
36
262
1.38
1.06
1.7
1.9
—
3.9
—
0
7
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
59
463
1.28
1.05
1.7
2.0
iu/l
3.4
4.6
0.53
20
180
(3017569) Oxygen content in Arterial blood
7
33
2.13
1.05
1.4
4.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
45
340
1.33
1.05
1.3
1.5
e6/l
213.1
12090.2
0.57
37
277
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
27
187
1.45
1.04
1.5
1.7
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
45
341
1.33
1.03
1.2
1.5
e6/l
121.7
21.9
0.41
37
264
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
5
22
2.28
1.03
1.2
1.0
u/ml
6.3
8.1
—
5
17
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
178
0.56
1.03
1.2
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
17
106
1.61
1.03
1.2
1.5
umol/l
10.8
9.9
0.45
17
100
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
41
307
1.34
1.02
1.4
1.4
mmol/l
7.0
6.7
0.26
29
214
(21494814) CD8 cells/100 lymphocytes in Specimen
9
47
1.92
1.02
1.7
2.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
53
1.89
1.01
1.1
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
70
861
0.81
1.00
1.6
1.5
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
9
48
1.88
1.00
1.2
1.3
—
52.5
—
0
8
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
36
265
1.37
1.00
1.2
1.1
iu/ml
21.1
1759.0
0.53
15
75
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
35
2.00
1.00
1.7
2.2
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
7
35
2.00
1.00
1.0
1.1
—
52.4
—
0
5
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
69
557
1.25
0.99
1.1
1.1
u/ml
2.8
4.0
—
7
90
(4146454)
15
92
1.64
0.97
2.6
2.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
383
3541
1.10
0.95
1.4
1.4
g/l
2.2
2.2
0.10
252
2253
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
42
545
0.77
0.94
1.1
1.2
—
—
—
0
0
(1002224) Polysomnography panel
91
763
1.20
0.93
1.1
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
29
209
1.39
0.92
3.1
3.6
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
19
126
1.51
0.91
1.1
1.1
ratio
1.0
1.0
—
6
48
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
16
102
1.57
0.90
1.6
1.4
pmol/l
30.0
76.2
—
8
27
(3006653) Thiamine [Moles/volume] in Blood
11
63
1.75
0.90
1.7
1.6
nmol/l
149.9
142.2
0.11
11
63
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
12
71
1.69
0.89
1.8
2.3
ug/l
14.3
19.5
1.35
12
71
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
36
272
1.33
0.87
1.1
1.3
u/ml
2.8
4.6
0.56
11
98
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
107
917
1.18
0.87
1.4
1.3
miu/ml
224.6
231.1
0.06
47
473
(3035880) pH of Pleural fluid
6
30
2.00
0.87
1.0
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
85
714
1.20
0.86
1.4
2.6
g/l
65.8
67.9
1.67
76
663
(3025941) Bacteria identified in Stool by Culture
111
955
1.17
0.86
1.2
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
11
64
1.72
0.86
1.9
2.2
u/ml
690.3
674.5
0.03
11
64
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
12
72
1.67
0.85
1.2
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
183
1636
1.13
0.84
1.6
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
16
104
1.54
0.84
1.0
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
33
248
1.34
0.83
1.1
1.1
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
6
111
0.54
0.83
1.3
1.2
nmol/l
1.2
1.4
—
6
100
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
77
644
1.20
0.83
2.1
2.0
ug/l
11.8
6.0
0.53
64
565
(3024891) Influenza virus A+B Ag [Presence] in Specimen
36
465
0.77
0.81
1.2
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
14
89
1.58
0.81
1.0
1.1
miu/ml
1125.9
1504.3
0.78
14
89
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
33
1.82
0.79
1.2
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
33
1.82
0.79
1.2
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
33
1.82
0.79
1.2
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
33
1.82
0.79
1.2
1.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
12
74
1.63
0.78
1.3
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
77
649
1.19
0.78
1.8
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
259
2376
1.10
0.77
1.5
1.8
%
1.3
1.4
1.85
228
2147
(1761868) Lipid panel - Serum or Plasma
655
6250
1.07
0.77
2.3
2.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
11
67
1.65
0.75
2.1
2.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
695
6654
1.07
0.74
8.1
7.6
e9/l
0.0
0.0
0.28
615
5425
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
430
4565
0.92
0.74
3.0
2.7
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
19
133
1.43
0.73
1.5
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
30
228
1.32
0.73
4.1
5.3
umol/l
371.4
364.6
0.09
25
195
(3014271) Vancomycin [Susceptibility]
5
26
1.93
0.70
2.4
2.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1413
13866
1.07
0.70
12.7
11.6
%
13.3
13.4
2.01
1386
13588
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
58
1.55
0.69
1.0
1.0
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
11
169
0.65
0.69
2.5
4.2
u/ml
30.0
1651.1
0.59
11
160
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
5
27
1.85
0.68
1.0
1.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
15
102
1.47
0.67
1.2
1.7
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
96
837
1.15
0.67
1.6
1.5
mg/l
3.5
4.0
0.23
67
559
(3035320) C reactive protein [Mass/volume] in Body fluid
7
121
0.58
0.67
3.6
2.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
149
1339
1.12
0.67
6.0
3.8
mmol/l
1.0
1.0
0.04
142
1253
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
43
1.63
0.67
1.9
2.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
36
285
1.27
0.66
1.2
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
115
1017
1.14
0.66
16.4
12.1
inr
1.3
1.1
0.44
18
163
(3004588) Protein electrophoresis panel - Serum or Plasma
66
559
1.19
0.66
1.4
2.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
423
3996
1.08
0.66
1.6
1.5
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
12
78
1.54
0.65
6.1
4.8
mg/l
10.3
10.0
0.12
12
72
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
70
1.57
0.65
1.2
1.8
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
10
62
1.62
0.65
1.3
1.3
g/l
30.1
33.9
—
10
53
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
99
868
1.15
0.65
1.4
1.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
57
477
1.20
0.65
1.9
1.6
nmol/l
38.5
40.9
0.34
57
469
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
29
224
1.30
0.65
2.0
2.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
70
816
0.85
0.64
9.5
6.9
—
—
—
0
0
(44806071)
5
29
1.73
0.64
1.2
1.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
5
29
1.73
0.64
1.4
1.2
pmol/l
217.6
333.4
—
5
18
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
16
112
1.43
0.63
1.2
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
153
1383
1.12
0.63
4.9
5.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
95
836
1.14
0.60
1.1
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
183
1676
1.10
0.60
1.8
1.7
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.0
—
0.1
—
0
12
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
95
838
1.14
0.59
2.5
2.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
361
3407
1.07
0.58
3.6
3.0
ph
7.4
7.4
0.22
108
630
(3002179) Metamyelocytes/100 leukocytes in Blood
111
990
1.13
0.58
3.1
4.1
%
0.9
0.6
0.20
24
195
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
6
35
1.72
0.57
1.0
1.1
—
78.2
—
0
5
(3039443) Prostate specific Ag panel - Serum or Plasma
16
219
0.73
0.57
1.3
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
218
2350
0.92
0.56
1.2
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
191
1759
1.10
0.56
3.7
3.5
%
21.0
21.0
0.02
85
701
(3051611) Lipemic interference index of Serum or Plasma
14
98
1.43
0.56
3.5
2.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
103
1154
0.89
0.56
1.3
1.4
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
21
159
1.32
0.55
1.1
1.2
mg/l
29.8
37.8
0.54
15
128
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
294
2764
1.08
0.54
1.4
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
17
125
1.36
0.53
1.1
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
13
91
1.43
0.53
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
34
277
1.23
0.52
1.1
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
19
143
1.33
0.52
1.2
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
16
117
1.37
0.52
1.2
1.3
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
6
40
1.50
0.51
1.0
2.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
17
126
1.35
0.51
1.1
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
64
1.41
0.51
1.1
1.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
25
314
0.79
0.51
3.2
4.3
mmol/l
1.1
1.4
1.23
25
307
(3006922) Hepatitis E virus Ab [Presence] in Serum
15
109
1.38
0.51
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
11
75
1.47
0.50
1.2
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
63
548
1.15
0.49
1.7
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
67
1.50
0.49
1.4
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
14
101
1.39
0.49
1.2
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
7
45
1.56
0.49
1.3
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
15
110
1.37
0.48
1.8
2.1
pg
30.7
32.4
0.41
15
110
(4211845)
11
76
1.45
0.48
2.1
2.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
15
200
0.75
0.48
1.1
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
106
959
1.11
0.47
2.4
2.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
7
48
1.46
0.46
1.3
1.5
—
—
—
0
0
(4024509)
15
111
1.35
0.46
1.9
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
11
77
1.43
0.45
1.4
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
122
1116
1.10
0.44
1.1
1.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
39
330
1.19
0.44
4.7
3.5
u/ml
19.2
785.8
0.94
33
276
(3033658) Prothrombin time (PT) actual/Normal
317
3332
0.94
0.44
3.5
3.0
%
95.0
96.2
0.39
304
3234
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
27
220
1.23
0.43
1.3
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
27
220
1.23
0.43
1.3
1.2
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
21
166
1.27
0.43
1.5
1.4
mu/l
21.9
41.3
1.22
21
150
(3033705) Calcium.ionized [Moles/volume] in Venous blood
14
104
1.35
0.43
2.3
2.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
31
1.61
0.43
1.2
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
31
1.61
0.43
1.2
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
31
1.61
0.43
1.2
1.0
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
15
0.00
0.41
0.0
1.1
—
7.8
—
0
7
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
15
0.00
0.41
0.0
1.1
—
2.7
—
0
7
(3004959) Base excess in Arterial cord blood by calculation
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
16
0.00
0.41
0.0
2.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(44806420)
0
18
0.00
0.40
0.0
2.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
28
232
1.21
0.40
2.5
2.9
kpa
9.1
8.8
0.27
28
218
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
397
4133
0.95
0.39
2.3
2.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
13
97
1.34
0.39
4.6
7.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
5
35
1.43
0.39
1.6
1.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
14
106
1.32
0.39
3.4
3.4
u/ml
30.0
63.3
0.79
14
106
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
19
0.00
0.39
0.0
1.5
—
12.3
—
0
14
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
133
1.28
0.38
1.2
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
32
377
0.85
0.38
1.2
1.3
—
—
—
0
0
(4198724)
8
113
0.71
0.37
2.5
2.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
37
1.35
0.37
1.2
4.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
20
161
1.24
0.37
1.3
3.9
—
—
—
0
0
(44813793)
17
134
1.27
0.37
1.1
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
24
198
1.21
0.36
1.4
1.8
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
81
1.36
0.36
2.1
5.8
%
10.5
11.5
0.41
11
81
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
5
78
0.64
0.35
2.0
1.5
ug/l
16.5
120.5
—
5
70
(21494890) Protein electrophoresis panel - 24 hour Urine
5
80
0.62
0.35
1.2
2.3
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
14
108
1.30
0.35
2.3
2.2
mmol/l
106.3
105.9
0.18
14
108
(3041354) Potassium [Moles/volume] in Venous blood
14
108
1.30
0.35
2.3
2.2
mmol/l
4.0
3.9
0.37
14
108
(3021901) Oxygen saturation in Capillary blood
18
144
1.25
0.35
2.4
2.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
17
135
1.26
0.35
1.1
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
16
126
1.27
0.35
1.4
1.2
u/ml
0.1
0.7
—
8
46
(3000850) Epithelial cells [#/volume] in Urine
252
2645
0.95
0.35
2.3
2.1
e6/l
11.6
7.7
0.50
220
2290
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
24
199
1.21
0.35
1.1
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
116
1075
1.08
0.34
3.0
4.3
%
0.7
0.9
0.23
30
259
(3011288) Drugs identified in Urine by Screen method
96
883
1.09
0.34
2.8
2.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
139
1299
1.08
0.34
1.4
1.4
iu/l
21.9
23.4
0.23
128
1096
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
45
1.33
0.33
1.0
1.1
—
—
—
0
0
(4027681)
16
127
1.26
0.33
1.3
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
49
435
1.13
0.33
1.8
1.5
nmol/l
0.4
0.5
0.47
41
358
(3015377) Calcium [Moles/volume] in Serum or Plasma
425
4109
1.04
0.33
2.5
2.7
mmol/l
2.3
2.3
0.08
376
3695
(3045414) Leukocytes [Presence] in Urine
59
655
0.90
0.32
1.4
1.7
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
10
74
1.35
0.32
1.8
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
40
351
1.14
0.32
2.8
2.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
14
110
1.27
0.31
1.4
1.2
—
—
—
0
0
(4035726)
105
974
1.08
0.31
1.5
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
20
165
1.21
0.31
1.3
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
97
0.72
0.31
1.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
20
240
0.83
0.30
4.2
3.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
106
986
1.08
0.30
3.1
4.4
%
0.2
0.5
0.19
25
200
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
14
111
1.26
0.30
1.0
1.1
u/l
1.0
1.0
—
6
50
(3021440) Promyelocytes/100 leukocytes in Blood
111
1038
1.07
0.28
3.1
4.3
%
0.1
0.2
0.86
29
240
(40768793) Breast Pathology biopsy report
30
344
0.87
0.28
1.5
1.2
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
13
103
1.26
0.28
1.2
1.3
—
64.6
—
0
12
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
91
979
0.93
0.28
1.6
2.1
ml/min/173m2
78.7
77.6
0.08
27
360
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1435
14222
1.04
0.27
9.2
8.1
ml/min/173m2
91.6
92.5
0.98
1187
11412
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
18
150
1.20
0.26
1.0
1.1
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
5
73
0.68
0.26
2.6
2.0
nmol/l
83.6
158.5
—
5
64
(3020876) Protein [Mass/time] in 24 hour Urine
9
74
1.22
0.25
1.8
1.9
—
3.2
—
0
10
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
44
397
1.11
0.25
2.1
1.9
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
6
81
0.74
0.24
2.3
4.0
mg/l
3.8
8.6
—
6
72
(3037756) Immunofixation for Serum or Plasma
19
161
1.18
0.24
1.1
1.4
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
6
82
0.73
0.24
1.0
1.2
u/l
70.5
398.5
—
6
74
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
33
293
1.13
0.24
1.4
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
85
0.70
0.24
1.5
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
85
0.70
0.24
1.5
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
85
0.70
0.24
1.5
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
91
0.77
0.22
2.4
3.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
64
690
0.93
0.22
1.2
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
138
1314
1.05
0.22
2.6
2.6
ug/l
0.7
0.7
0.26
80
744
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
11
0.00
0.21
0.0
2.9
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
10
0.00
0.21
0.0
2.1
—
133.1
—
0
10
(3022229) Phosphate [Moles/volume] in Urine
0
10
0.00
0.21
0.0
3.3
—
13.6
—
0
10
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
104
0.77
0.21
1.0
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
13
0.00
0.21
0.0
1.1
—
16.1
—
0
13
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
10
123
0.81
0.20
1.1
1.0
mg/l
287.2
295.4
—
10
112
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
50
461
1.09
0.20
1.1
1.1
u/ml
3.2
2.4
0.15
13
112
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
50
1.20
0.19
1.5
1.8
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
133
0.83
0.19
1.4
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
51
1.18
0.19
1.2
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
57
530
1.08
0.19
2.0
1.6
iu/ml
0.0
0.2
—
8
99
(3012441) Differential panel - Pleural fluid
6
52
1.15
0.19
1.2
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
35
318
1.10
0.19
1.0
1.0
u/ml
1.2
2.7
1.23
16
166
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
132
0.83
0.18
1.4
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
132
0.83
0.18
1.4
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
132
0.83
0.18
1.4
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
132
0.83
0.18
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
132
0.83
0.18
1.4
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
61
1.15
0.17
1.1
1.1
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
7
63
1.11
0.17
1.3
1.2
mmol/l
5.4
6.5
—
7
56
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
17
194
0.88
0.16
1.2
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
56
525
1.07
0.16
1.1
1.1
u/ml
3.1
1.5
0.46
27
210
(3036071) Salmonella sp Ab [Titer] in Serum
6
76
0.79
0.15
1.0
1.1
—
—
—
0
0
(4281824)
15
130
1.16
0.15
1.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
121
1164
1.04
0.15
2.4
2.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
46
491
0.94
0.14
1.3
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
10
118
0.85
0.14
1.5
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
18
160
1.13
0.14
1.1
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
47
443
1.06
0.12
1.6
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
104
1.15
0.12
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
104
1.15
0.12
1.1
1.0
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
31
334
0.93
0.12
1.1
1.0
u/ml
1.0
0.4
—
7
73
(3002523) Influenza virus A Ag [Presence] in Specimen
35
375
0.93
0.12
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
35
375
0.93
0.12
1.2
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
317
1.07
0.12
1.4
1.9
g/l
7.0
7.4
0.82
22
260
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
317
1.07
0.12
1.4
1.8
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
317
1.07
0.12
1.4
1.9
g/l
3.7
3.9
0.30
19
249
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
92
887
1.04
0.11
3.5
4.0
ug/l
17.5
20.8
0.10
75
684
(3041806) Other cells [#/volume] in Blood by Manual count
14
157
0.89
0.11
1.4
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
46
485
0.95
0.10
1.3
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
15
167
0.90
0.10
1.7
2.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
92
951
0.97
0.10
2.8
3.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
300
1.07
0.10
1.4
1.8
g/l
9.8
10.2
0.29
23
267
(3014599) Egg white IgE Ab [Units/volume] in Serum
15
166
0.90
0.09
1.1
1.0
u/ml
0.4
1.1
—
6
42
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
46
1.09
0.09
2.6
2.1
umol/l
15.3
16.4
—
5
46
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
47
1.06
0.09
1.4
1.4
ug/l
9.2
8.0
—
5
47
(3029075) Extractable nuclear Ab panel - Serum
5
47
1.06
0.09
1.2
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
47
1.06
0.09
1.4
1.7
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
15
165
0.91
0.09
1.1
1.1
u/ml
0.8
3.7
—
7
54
(3021447) Carbon dioxide [Partial pressure] in Venous blood
88
907
0.97
0.08
4.5
3.2
kpa
5.8
5.9
0.26
83
878
(3034426) Prothrombin time (PT)
6
58
1.03
0.08
1.3
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
17
156
1.09
0.08
1.1
1.3
g/l
6.4
6.3
—
10
111
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
17
156
1.09
0.08
1.2
1.1
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
17
156
1.09
0.08
1.1
1.3
g/l
3.0
3.0
0.01
12
111
(3024139) IgG subclass 3 [Mass/volume] in Serum
17
156
1.09
0.08
1.1
1.3
g/l
0.4
0.4
0.25
12
110
(3023183) Ammonium ion [Moles/volume] in Plasma
22
205
1.07
0.08
2.3
2.7
umol/l
27.7
33.9
1.46
17
176
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
14
127
1.10
0.08
1.4
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
33
313
1.06
0.07
1.4
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
38
398
0.95
0.07
1.1
1.1
u/ml
9.1
4.5
0.50
16
147
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
304
1.05
0.07
1.4
1.9
g/l
2.9
3.1
0.37
21
256
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
368
3718
0.99
0.07
2.3
2.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
52
539
0.96
0.07
3.1
2.8
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
50
482
1.04
0.06
1.1
1.1
u/ml
6.6
6.6
0.00
28
264
(3002032) Base excess in Venous blood by calculation
88
900
0.98
0.05
4.5
3.2
mmol/l
1.9
2.0
0.12
73
711
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
43
445
0.97
0.05
2.2
3.0
%
0.6
0.7
0.20
43
429
(4062490)
17
159
1.07
0.05
1.2
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
122
1238
0.98
0.04
2.4
2.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
19
180
1.06
0.04
1.4
1.7
—
26.6
—
0
12
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
70
686
1.02
0.04
1.7
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
13
121
1.07
0.03
2.2
2.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
258
2560
1.01
0.03
2.1
1.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
143
1415
1.01
0.03
1.4
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
100
987
1.01
0.03
2.6
2.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
27
279
0.97
0.02
2.1
1.6
nmol/l
0.9
0.9
0.08
22
239
(3051387) C reactive protein [Mass/volume] in Capillary blood
29
281
1.03
0.02
3.0
3.0
mg/l
22.1
22.0
0.01
13
174
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
200
2013
0.99
0.02
1.5
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
47
479
0.98
0.02
1.3
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
37
362
1.02
0.01
1.1
1.1
u/ml
3.4
4.7
0.30
16
140
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
14
133
1.05
0.01
1.4
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
241
2421
0.99
0.01
2.6
2.3
mosm/kgh2o
553.7
552.7
0.02
207
2033
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
22
213
1.03
0.01
1.6
1.5
—
12.0
—
0
33
(3027008) Opiates [Presence] in Urine
126
1251
1.01
0.01
2.4
2.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
23
237
0.97
0.01
2.2
2.5
ug/min
30.5
104.4
1.60
11
158
(3008401) Mugwort IgE Ab [Units/volume] in Serum
47
463
1.02
0.01
1.1
1.1
u/ml
0.9
1.5
0.31
24
192
(3045142) Bone marrow Pathology biopsy report
11
104
1.06
0.01
1.4
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
125
1243
1.01
0.00
2.5
2.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
18
174
1.03
0.00
1.1
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
24
246
0.98
0.00
1.3
1.7
g/l
0.6
0.8
0.46
17
191
(3028300) Cannabinoids [Presence] in Urine
126
1254
1.01
0.00
2.5
2.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
145
0.97
0.00
1.4
1.6
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
21
206
1.02
0.00
1.5
3.5
—
1.9
—
0
21
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
10
97
1.03
0.00
1.5
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
10
103
0.97
0.00
1.4
1.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
19
187
1.02
0.00
1.4
1.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
34
337
1.01
0.00
1.4
1.4
ug/g
228.4
302.0
0.82
14
173
(3013862) HLA-DP [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
87
0.92
0.00
1.4
1.6
—
—
—
0
0
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
26.2
—
0
6
(40760410) HLA-B [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
5
56
0.89
0.00
1.4
1.6
pmol/l
17.8
14.1
—
5
47
(3022725) Serotonin [Moles/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
1115.3
—
0
6
(3024263) Appearance of Synovial fluid
5
56
0.89
0.00
1.6
1.8
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.6
—
197.5
—
0
8
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
8
0.00
0.00
0.0
1.8
—
1.9
—
0
8
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.2
—
734.2
—
0
5
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
18
180
1.00
0.00
2.9
2.7
mmol/l
7.2
6.9
0.13
18
175
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
38
380
1.00
0.00
1.4
1.3
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
7
0.00
0.00
0.0
4.6
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
9
0.00
0.00
0.0
1.1
—
8.0
—
0
9
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
7
71
0.99
0.00
1.0
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
9
99
0.91
0.00
1.0
1.1
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
72
0.97
0.00
1.4
1.3
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
118.8
—
0
5
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
18
180
1.00
0.00
1.2
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
68
0.88
0.00
1.0
1.1
iu/ml
230.8
207.8
—
6
68
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
57
0.88
0.00
1.6
1.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
67
0.90
0.00
1.0
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.6
1.8
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
5.9
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_FAMILY_HISTORY_CERTA_DISABILITI_CHRONIC_DISEA_LEADI_DISABL – Family history of certain disabilities and chronic diseases leading to disablement

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).